{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":10,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":10,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"416724d61cad","filters":{"venue":"Drug Target Insights"}},"results":[{"id":"W2277636392","doi":"10.4137/dti.s9442","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Neuroinflammation; Angiogenesis; Matrix metalloproteinase; Inflammation; Cancer research; Gene silencing; Pharmacology; Blood–brain barrier; Medicine; Chemistry; Biology; Immunology; Central nervous system; Internal medicine; Biochemistry; Gene","authors":[{"name":"Borhane Annabi","is_ca":false},{"name":"Simon Lord‐Dufour","is_ca":true},{"name":"Amélie Vézina","is_ca":false},{"name":"Richard Béliveau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01167545568328855,"gpt":0.2453272270426369,"spread":0.2336517713593484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007434777,0.0003503328,0.0006183056,0.0003456786,0.0001815999,0.00002173245,0.0001248559,0.0002264865,0.0002600555],"category_scores_gemma":[0.0002030858,0.0002644603,0.0001621879,0.0002773035,0.0001201687,0.0002565831,0.00008057414,0.0003759799,0.00003139673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000922764,"about_ca_system_score_gemma":0.0001354473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002198356,"about_ca_topic_score_gemma":0.00001037739,"domain_scores_codex":[0.9974006,0.0001872159,0.0007030049,0.0003957064,0.0007491889,0.0005642548],"domain_scores_gemma":[0.998418,0.0002180604,0.0003080943,0.0003973855,0.0002120331,0.0004463974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004183392,0.0002033659,0.03123338,0.0003101066,0.0002023705,0.00004833759,0.0101182,0.000004994728,0.9473037,0.000187247,0.009092781,0.0008771719],"study_design_scores_gemma":[0.005563694,0.0003507853,0.01385888,0.0001545219,0.0002127599,0.0000556242,0.001883148,0.001039643,0.9498715,0.0001163049,0.02652792,0.0003651826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878978,0.004871414,0.0001000978,0.001506767,0.00082725,0.0007314425,0.00002197639,0.00006660097,0.003976696],"genre_scores_gemma":[0.9953458,0.000163511,0.001303988,0.0008049007,0.0014763,0.00002296988,0.00008583825,0.00005479308,0.0007419046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01743514,"threshold_uncertainty_score":0.9999807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1759449679","doi":"10.4137/dti.s1146","title":"A Model for NAD(P)H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Cancer research; Chemotherapy; Benzoquinone; NAD+ kinase; Medicine; Bone marrow; Pharmacology; Chemistry; Enzyme; Biochemistry; Immunology; Internal medicine","authors":[{"name":"Asher Begleiter","is_ca":true},{"name":"Nadia El-Gabalawy","is_ca":true},{"name":"Laurie Lange","is_ca":true},{"name":"Marsha K. Leith","is_ca":true},{"name":"Lynn J. Guziec","is_ca":false},{"name":"Frank S. Guziec","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1245756610171152,"gpt":0.4309202822431206,"spread":0.3063446212260053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002904749,0.0004375273,0.0005002142,0.0001824125,0.0005181223,0.00005111868,0.0004493703,0.0003138411,0.0009170782],"category_scores_gemma":[0.00002810524,0.000385774,0.0002547238,0.0002784698,0.0001587363,0.0002468562,0.00003941568,0.0004964525,0.00003957031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001143086,"about_ca_system_score_gemma":0.0002137791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002676952,"about_ca_topic_score_gemma":0.00003023203,"domain_scores_codex":[0.9978272,0.000183644,0.0004458853,0.0006000872,0.0002333282,0.0007098198],"domain_scores_gemma":[0.9988465,0.0001141306,0.0002222767,0.0002743337,0.0001972523,0.0003455204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004285004,0.00425333,0.002525673,0.0001638984,0.001283804,0.0001009421,0.02091758,0.006058399,0.4528198,0.01664848,0.46334,0.0276031],"study_design_scores_gemma":[0.009051431,0.0001962849,0.001321392,0.00003610273,0.0002096911,0.00001041713,0.000171793,0.1944365,0.2204102,0.02583484,0.547259,0.00106231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810137,0.004087419,0.00258688,0.005092712,0.001754054,0.001408506,0.0007487994,0.0002891125,0.003018849],"genre_scores_gemma":[0.9753218,0.000558758,0.006024096,0.01338375,0.0005731324,0.0002011018,0.0003002349,0.00005002759,0.003587096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2324096,"threshold_uncertainty_score":0.9999962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385283736","doi":"10.33393/dti.2012.1373","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Medicine; Inflammation; Matrix metalloproteinase; Bioinformatics; Carcinogen; Cancer research; Pharmacology; Neuroscience; Internal medicine; Biology; Genetics","authors":[{"name":"Borhane Annabi","is_ca":true},{"name":"Simon Lord‐Dufour","is_ca":true},{"name":"Amélie Vézina","is_ca":true},{"name":"Richard Béliveau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007731154081757723,"gpt":0.2262672031747568,"spread":0.218536049092999,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834498,0.0002361626,0.0002139933,0.0000984602,0.000118044,0.00002548918,0.0001774151,0.0001663795,0.00004806836],"category_scores_gemma":[0.0001531938,0.0002294569,0.0001328922,0.0000965557,0.00007071547,0.00002338169,0.0001456627,0.00009916659,0.00001182932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002826984,"about_ca_system_score_gemma":0.00008623386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007271144,"about_ca_topic_score_gemma":0.0000158668,"domain_scores_codex":[0.9984576,0.0001796937,0.000354553,0.000361153,0.0002876236,0.0003593574],"domain_scores_gemma":[0.9990755,0.00003995778,0.0002066956,0.0003694377,0.0001087346,0.0001996912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009212711,0.00008176986,0.01733755,0.00006927668,0.0000919719,0.000003923046,0.001007288,0.00001086907,0.9781007,0.00006427352,0.002891172,0.000249119],"study_design_scores_gemma":[0.0009016957,0.00005950449,0.004520869,0.00001327281,0.00003852435,0.000006090976,0.0002726014,0.00008697707,0.9770549,0.00009305726,0.01668447,0.0002680156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928023,0.005116643,0.0001542556,0.0001108342,0.0003111444,0.0003272151,0.00006375862,0.0000185867,0.001095224],"genre_scores_gemma":[0.9982467,0.00008071643,0.000523556,0.0001981663,0.0005430807,0.00002122648,0.0002020195,0.00003877333,0.000145777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0137933,"threshold_uncertainty_score":0.9356979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215818202","doi":"10.33393/dti.2021.2347","title":"Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury","year":2021,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lakehead University","funders":"European Society of Intensive Care Medicine; Ministero dell’Istruzione, dell’Università e della Ricerca; Società Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva","keywords":"Medicine; ARDS; Bronchoalveolar lavage; Lung; Inflammation; Pulmonary fibrosis; Fibrosis; Pulmonary compliance; Pathology; Internal medicine","authors":[{"name":"Vanessa Zambelli","is_ca":false},{"name":"Laura Rizzi","is_ca":false},{"name":"P. Delvecchio","is_ca":false},{"name":"Elena Bresciani","is_ca":false},{"name":"Emanuele Rezoagli","is_ca":false},{"name":"Laura Molteni","is_ca":false},{"name":"Ramona Meanti","is_ca":false},{"name":"Maria Serena Cuttin","is_ca":false},{"name":"Giorgio Bovo","is_ca":false},{"name":"Silvia Coco","is_ca":false},{"name":"Robert J. Omeljaniuk","is_ca":true},{"name":"Vittorio Locatelli","is_ca":false},{"name":"Giacomo Bellani","is_ca":false},{"name":"Antonio Torsello","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006968065066650779,"gpt":0.2440030085911945,"spread":0.2370349435245437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001662469,0.0002252146,0.0004075757,0.0002223395,0.00009252178,0.00004532773,0.00007284828,0.0001568479,0.0002911803],"category_scores_gemma":[0.00006342051,0.0002026945,0.00007802311,0.0003434556,0.00001940402,0.0002818846,0.00009831182,0.0002392931,0.00002535237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007744988,"about_ca_system_score_gemma":0.0001898219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001995788,"about_ca_topic_score_gemma":0.00004074961,"domain_scores_codex":[0.998493,0.00006874617,0.0004466039,0.0004210752,0.0002780212,0.0002925957],"domain_scores_gemma":[0.9991434,0.00003418024,0.00009137186,0.0003482554,0.0001814383,0.0002014184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003921187,0.0002647074,0.02367788,0.0006467426,0.0004226721,0.001838834,0.008100701,0.00008053335,0.9313644,0.01930668,0.01033245,0.003572316],"study_design_scores_gemma":[0.001648137,0.00009087829,0.002784075,0.0002627237,0.0001482723,0.00005064799,0.0004625963,0.01810208,0.9309146,0.00901465,0.03612836,0.0003929884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942467,0.002550505,0.001040729,0.0008015228,0.0003587532,0.0003812686,0.00001600427,0.00009032292,0.000514195],"genre_scores_gemma":[0.9932962,0.000400959,0.003720291,0.0006027961,0.0001871517,0.00003694507,0.0002356936,0.00004109017,0.001478879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02579591,"threshold_uncertainty_score":0.8265642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1496935185","doi":"10.4137/dti.s447","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Reverse cholesterol transport; Cholesterol; Medicine; Internal medicine; Endocrinology; Lipoprotein; High-density lipoprotein; Excretion; Endogeny","authors":[{"name":"Fabrizio S. Chiacchia","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01994909584585498,"gpt":0.2353904733805925,"spread":0.2154413775347375,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933468,0.0002567752,0.0005493482,0.0001914223,0.0002016849,0.00003146406,0.0001085671,0.00009102671,0.00009413783],"category_scores_gemma":[0.00008335349,0.0002016853,0.0001869,0.0001980332,0.000125857,0.0001718558,0.00007330484,0.0001962557,0.0001824297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003532953,"about_ca_system_score_gemma":0.00007304608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003049405,"about_ca_topic_score_gemma":0.0002498173,"domain_scores_codex":[0.998478,0.0001015547,0.0002486183,0.0004163066,0.0004244304,0.0003310899],"domain_scores_gemma":[0.998835,0.00004629552,0.00004519668,0.0005482034,0.000107381,0.0004179421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001178137,0.002049248,0.03549106,0.0008413044,0.004336245,0.003081663,0.1232615,0.00009300251,0.01256751,0.001185407,0.06811941,0.7477955],"study_design_scores_gemma":[0.002918253,0.0002274866,0.3675941,0.0001330169,0.0001294979,0.0002317401,0.0003468054,0.00003804545,0.02066773,0.0006658428,0.6065875,0.0004599564],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881586,0.005508192,0.0002418042,0.0007606765,0.0001780754,0.0006659467,0.00001577455,0.0001414245,0.004329464],"genre_scores_gemma":[0.9910097,0.0002408706,0.002473888,0.002669779,0.0004650097,0.00006527589,0.00002481232,0.00004798332,0.003002728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7473355,"threshold_uncertainty_score":0.8224488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252246510","doi":"10.33393/dti.2008.1333","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Medicine; Cholesterol; Ldl cholesterol; Internal medicine; Bioinformatics; Intensive care medicine; Biology","authors":[{"name":"Fabrizio S. Chiacchia","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01994909584585498,"gpt":0.2353904733805925,"spread":0.2154413775347375,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933468,0.0002567752,0.0005493482,0.0001914223,0.0002016849,0.00003146406,0.0001085671,0.00009102671,0.00009413783],"category_scores_gemma":[0.00008335349,0.0002016853,0.0001869,0.0001980332,0.000125857,0.0001718558,0.00007330484,0.0001962557,0.0001824297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003532953,"about_ca_system_score_gemma":0.00007304608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003049405,"about_ca_topic_score_gemma":0.0002498173,"domain_scores_codex":[0.998478,0.0001015547,0.0002486183,0.0004163066,0.0004244304,0.0003310899],"domain_scores_gemma":[0.998835,0.00004629552,0.00004519668,0.0005482034,0.000107381,0.0004179421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001178137,0.002049248,0.03549106,0.0008413044,0.004336245,0.003081663,0.1232615,0.00009300251,0.01256751,0.001185407,0.06811941,0.7477955],"study_design_scores_gemma":[0.002918253,0.0002274866,0.3675941,0.0001330169,0.0001294979,0.0002317401,0.0003468054,0.00003804545,0.02066773,0.0006658428,0.6065875,0.0004599564],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881586,0.005508192,0.0002418042,0.0007606765,0.0001780754,0.0006659467,0.00001577455,0.0001414245,0.004329464],"genre_scores_gemma":[0.9910097,0.0002408706,0.002473888,0.002669779,0.0004650097,0.00006527589,0.00002481232,0.00004798332,0.003002728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7473355,"threshold_uncertainty_score":0.8224488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1546961109","doi":"10.4137/dti.s378","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Gene silencing; Bioinformatics; Genetic enhancement; Ataxia; Drug discovery; Nanocarriers; Computational biology; Drug; Neuroscience; Gene; Biology; Pharmacology; Genetics; Pathology; Psychiatry","authors":[{"name":"Satya Prakash","is_ca":true},{"name":"Meenakshi Malhotra","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04820452856902558,"gpt":0.2393625561885666,"spread":0.191158027619541,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006469794,0.0002126391,0.0002392353,0.0001469475,0.00005007132,0.000005852197,0.0001538804,0.00007322121,0.00001908838],"category_scores_gemma":[0.00001753806,0.0001996864,0.00004583246,0.00008880685,0.000139166,0.00001794348,0.0000968989,0.00008710138,0.00000193069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001659491,"about_ca_system_score_gemma":0.0001073308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003247454,"about_ca_topic_score_gemma":0.0002057819,"domain_scores_codex":[0.9987534,0.0001504525,0.0003190128,0.0004027886,0.0001469872,0.0002273323],"domain_scores_gemma":[0.9994453,0.00001278255,0.0000972979,0.0002546984,0.0001022913,0.00008759955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003717553,0.002871177,0.1027488,0.0006910856,0.000554974,0.0013105,0.01601547,0.004691972,0.7947614,0.002343263,0.002279547,0.06801423],"study_design_scores_gemma":[0.002908694,0.0007640554,0.1422173,0.0001622457,0.000033989,0.00001933037,0.002591694,0.001357394,0.7000107,0.001224027,0.1476054,0.001105164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8659911,0.1331246,0.00002163481,0.0002332409,0.00008250815,0.0001746485,0.00002769203,0.00000570011,0.0003389343],"genre_scores_gemma":[0.7560316,0.2432626,0.0001221349,0.0002519607,0.00002936789,0.00002304797,0.0001275663,0.00001485174,0.0001367815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1453259,"threshold_uncertainty_score":0.8142973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385284415","doi":"10.33393/dti.2009.1337","title":"A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Medicine; Chemotherapy; Cancer imaging; Cancer chemotherapy; Oncology; NAD+ kinase; Cancer; Internal medicine; Medical physics; Bioinformatics; Cancer research; Biology; Biochemistry; Enzyme","authors":[{"name":"Asher Begleiter","is_ca":true},{"name":"Nadia El-Gabalawy","is_ca":true},{"name":"Laurie Lange","is_ca":true},{"name":"Marsha K. Leith","is_ca":true},{"name":"Lynn J. Guziec","is_ca":false},{"name":"Frank S. Guziec","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1214002722564105,"gpt":0.4299540723818994,"spread":0.3085538001254889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002916013,0.0004426018,0.0005035236,0.0001840133,0.0005246404,0.00005194039,0.0004551176,0.0003183772,0.0009621379],"category_scores_gemma":[0.00002788883,0.0003903439,0.0002573479,0.0002815438,0.0001606644,0.0002473708,0.00004052778,0.0005011124,0.00004061553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001137743,"about_ca_system_score_gemma":0.0002103738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002288187,"about_ca_topic_score_gemma":0.00002464557,"domain_scores_codex":[0.9978075,0.0001816301,0.0004487222,0.0006071427,0.0002355814,0.0007193919],"domain_scores_gemma":[0.9988369,0.0001131113,0.0002234414,0.0002773571,0.0001998621,0.0003492684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004261055,0.004189475,0.002427448,0.0001646264,0.001290389,0.0001049806,0.01920116,0.006356073,0.4458682,0.01656841,0.4705331,0.02903505],"study_design_scores_gemma":[0.008864115,0.0001927486,0.001266579,0.00003502026,0.0002068946,0.00001043559,0.0001514789,0.1982723,0.2202243,0.02512953,0.5446088,0.001037806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801489,0.00417804,0.002809405,0.005207472,0.001790831,0.001468936,0.0007697131,0.0003001905,0.003326551],"genre_scores_gemma":[0.9744982,0.00055903,0.006387419,0.01355512,0.0005819,0.0002055618,0.0003047749,0.00005092825,0.003857123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2256439,"threshold_uncertainty_score":0.9999511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4361197222","doi":"10.33393/dti.2008.1332","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Neuroscience; Bioinformatics; Intensive care medicine; Pathology; Psychology; Biology","authors":[{"name":"Satya Prakash","is_ca":true},{"name":"Meenakshi Malhotra","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04846771950011428,"gpt":0.2384463568752153,"spread":0.189978637375101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006249222,0.0001749451,0.0002164147,0.0001305526,0.00004949624,0.000003450876,0.00009617448,0.0000815137,0.00003606907],"category_scores_gemma":[0.00002788195,0.0001646322,0.00003697023,0.0000838833,0.0001275432,0.00001019327,0.00006528459,0.00008431013,0.000001808543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001220288,"about_ca_system_score_gemma":0.00008845803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001570912,"about_ca_topic_score_gemma":0.0001705743,"domain_scores_codex":[0.9988278,0.0002306394,0.0002787839,0.0003646353,0.0001119903,0.00018613],"domain_scores_gemma":[0.9995219,0.00001498536,0.00008694184,0.0002177179,0.00007424068,0.00008427262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003877595,0.001905546,0.05574913,0.0004355595,0.0002481268,0.0009983339,0.01062187,0.002855932,0.8863914,0.005949383,0.002273802,0.02869334],"study_design_scores_gemma":[0.003723931,0.0006206913,0.06284358,0.00006410988,0.00002724225,0.00003133303,0.001358622,0.0006791157,0.3234226,0.00118995,0.6051939,0.0008449393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9068847,0.0916994,0.0000789734,0.0003206268,0.0002163144,0.0002146489,0.00002676714,0.000007072641,0.0005515213],"genre_scores_gemma":[0.8112026,0.1874543,0.0003651109,0.0004173036,0.00005721032,0.00002926728,0.0001939475,0.00001684308,0.0002634399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6029201,"threshold_uncertainty_score":0.6713507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385439599","doi":"10.33393/dti.2013.1346","title":"Impact of Hepatocyte Growth Factor on Skeletal Myoblast Transplantation Late After Myocardial Infarction","year":2013,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Greenfield Research (Canada); Dalhousie University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Hepatocyte growth factor; Myocardial infarction; Transplantation; Skeletal muscle; Growth factor; Myocyte; Infarction; Cardiology; Internal medicine; Pathology","authors":[{"name":"Stacy B. O’Blenes","is_ca":true},{"name":"Audrey W. Li","is_ca":true},{"name":"Chris V. Bowen","is_ca":true},{"name":"Drew R. DeBay","is_ca":true},{"name":"Mohammed Althobaiti","is_ca":true},{"name":"J Clarke","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006742084129002327,"gpt":0.2469566290100468,"spread":0.2402145448810445,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003713538,0.000227997,0.0003383463,0.0002484102,0.00004500676,0.00001988815,0.00005912661,0.0001146518,0.0008685261],"category_scores_gemma":[0.000008283473,0.0001639173,0.0003003536,0.0001685573,0.0000490347,0.0002897215,0.000005306329,0.0001918289,0.0001635765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008029793,"about_ca_system_score_gemma":0.0000579303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004324971,"about_ca_topic_score_gemma":0.00000957191,"domain_scores_codex":[0.9988424,0.00005310504,0.0003479705,0.0002308673,0.0003128478,0.0002128086],"domain_scores_gemma":[0.9993707,0.00005043525,0.0001050581,0.0001800052,0.0001526466,0.0001411426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002962792,0.0008307361,0.886047,0.001416191,0.0008727539,0.0001759192,0.01425796,0.00006221465,0.08919574,0.0006932941,0.001891595,0.00159377],"study_design_scores_gemma":[0.001242621,0.0004679986,0.8984391,0.00009185563,0.00008564358,0.00001698316,0.00001390318,0.0001179235,0.09882554,0.0004043068,0.0001156313,0.0001784575],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972359,0.00003984197,0.0005421607,0.0001693763,0.0001528216,0.000619159,0.00009985285,0.0001393611,0.001001531],"genre_scores_gemma":[0.9981107,0.0004008531,0.0006193994,0.0002623253,0.0001261978,0.00005339397,0.0001986448,0.00003405695,0.0001945007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01424406,"threshold_uncertainty_score":0.9509751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}